HOME >> MEDICINE >> NEWS
End AIDS drug waiting lists, HIV care providers tell policymakers

WASHINGTON, DC--The nation's frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

In meetings with key congressional and Bush administration officials this week, the HIV Medicine Association (HIVMA) and the American Academy of HIV Medicine (AAHIVM) are telling policymakers to make access to medical care for low-income people with HIV/AIDS the top priority when reauthorizing the Ryan White CARE Act, the nation's primary federal program dedicated to providing care and support for people living with HIV/AIDS.

Ryan White includes a constellation of programs designed to fill in gaps in health coverage for uninsured or underinsured people with HIV/AIDS. Ryan White programs provide aid ranging from social and support services like legal services, child care, and housing assistance to access to antiretroviral medications through the AIDS Drug Assistance Program.

"However, Ryan White does not currently give medical care and basic medical services the priority they should receive in the era of highly active antiretroviral therapy (HAART)," says Paul Volberding, MD, chair of the HIVMA Board of Directors. "Two million years of life have been saved since the introduction of HAART. Access to these revolutionary medicines and the medical services required to deliver and manage their use should be given precedence when Congress renews Ryan White this year."

"Lack of funding has, furthermore, forced some states to start waiting lists for anti-AIDS drugs," notes AAHIVM Board of Directors chairman John Stansell, MD. "This is completely unacceptable. Patients need those medications to live. The federal government should guarantee access to these essential medicines for low-income people living with HIV/AIDS."

The two leading HIV medical associations collectively represent nearly all of the medical providers delivering HIV care in the United States in a w
'"/>


8-Mar-2005


Page: 1 2 3

Related medicine news :

1. Valve disease impacts survival while awaiting heart transplant
2. Major inequalities in access to kidney transplant waiting list revealed
3. Mayo clinic proceedings study supports shorter waiting period for driving privileges after a seizure
4. New procedure makes kidney transplant an option for thousands on waiting list
5. Patient protection laws dont favor health providers
6. Health care providers should be prepared for high prevalence of co-occurring disorders
7. Most child care is provided by informal providers, study finds
8. Health care providers approach to patient care linked to successful physician-patient relationships, study finds
9. Annual UNC-CH study shows state gaining health providers, but big imbalances remain
10. Researchers join with treatment providers to improve drug abuse treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: End AIDS drug waiting lists HIV care providers tell policymakers

(Date:5/20/2013)... Heritage Woods of Gurnee , a ... is hosting Breakfast and Bingo at 8:30 a.m. on ... at 3775 Grand Ave. in Gurnee, Illinois, serves older ... need some help to maintain their independence. , "Come ... bingo," says Tammy Temaner-Rosas, Director of Marketing for Heritage ...
(Date:5/20/2013)... MN (PRWEB) May 20, 2013 When a ... bed is only part of the process. Much of the ... the internet involves not knowing what to expect. Best ... advice consumers can use to ensure their purchase proves smooth. ... You Buy a Mattress Online ”, readers find helpful tips ...
(Date:5/20/2013)... 2013 Fastcare Miami Beach clinic ... within its first symptoms, as if not treated, it may ... serious infection. Although a urinary tract infection in itself is ... serious kidney infection called pyelonephritis. Women seem to have many ... to the same percentage as women after the age of ...
(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...
(Date:5/20/2013)... May 20, 2013 Leading facial plastic surgeon ... recognized as a “Top Doc” in the field of Otolaryngology ... , The Palm Beacher magazine, one of Palm Beach ... Docs” in the May/June 2013 issue, including 70 of the ... and dining, events, things to do, health and fitness, people ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: